[125I]IRL1620 [7694]



[125I]IRL1620


SMILES CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCC(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)CC
InChIKey DXPHNGAMYPPTBJ-TZMIJSMNSA-N
Sequence DEEAVYFAHLDIIW

Chemical Properties

Hydrogen bond acceptors 22
Hydrogen bond donors 23
Rotatable bonds 56
Log P -0.883
Molecular weight (Da) 1819.8
Stereochemistry info partial
Radioactive 125I


No bioactivity data available.

[125I]IRL1620


Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0


Compound is not listed as a drug.